financetom
Business
financetom
/
Business
/
Aon first-quarter profit grows on gains from investments, funds
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Aon first-quarter profit grows on gains from investments, funds
Apr 26, 2024 4:01 AM

(Reuters) - Aon reported a rise in first-quarter profit on Friday, powered by increases in interest earned from investments as well as funds held in a fiduciary capacity.

Interest income rose nearly six times to $28 million in the first quarter ended March, primarily due to interest earned on $5 billion investment of debt proceeds used to fund the purchase of NFP.

Last year, Aon agreed to buy privately held NFP in a deal valued at about $13.4 billion to tap the fast-growing middle-market segment of insurance brokerage, wealth management and retirement plan advisory.

Fiduciary investment income, which rose to $79 million in the quarter from $52 million a year ago, refers to interest earned on funds held in a fiduciary capacity by entities acting in a custodial role. These funds are typically held on behalf of policyholders, and the fiduciary has a legal obligation to manage them in the best interests of clients.

The U.S. Federal Reserve's higher-for-longer interest rate environment has helped such companies rake in higher income on funds and investments.

Last week, peer Marsh & McLennan also reported a better-than-expected first-quarter profit as fiduciary interest income rose 34% to $122 million.

Aon, which generates revenue through insurance, risk management services, consulting and advisory, reported adjusted net income attributable to shareholders of $1.13 billion, or $5.66 a share, for three months ended March 31, compared to $1.07 billion, or $5.17 a share, a year ago.

Revenue from commercial risk solutions unit rose about 2% to $1.81 billion, while that from reinsurance rose 8% to $1.17 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US Transportation Sec'y Duffy requests meeting with Boeing CEO on safety
US Transportation Sec'y Duffy requests meeting with Boeing CEO on safety
Feb 13, 2025
WASHINGTON, Feb 13 (Reuters) - U.S. Transportation Secretary Sean Duffy said on Thursday he has asked the CEO of Boeing ( BA ) to come to Washington, D.C., as soon as possible to discuss quality and safety issues at the company. Following that, I will visit Boeing ( BA ) myself to evaluate firsthand the measures being implemented to ensure...
Toyota Motor to Recall Sienna Minivans
Toyota Motor to Recall Sienna Minivans
Feb 13, 2025
03:48 PM EST, 02/13/2025 (MT Newswires) -- Toyota Motor ( TM ) said Thursday it is recalling Sienna minivan models from 2021 to 2025 in North America, Asia, and other regions, including roughly 168,000 in the US. The automaker said bolts connecting the split 60/40 third-row seat backs may not be tightened to the proper safety standards, which could prevent...
US Transportation Sec'y Duffy requests meeting with Boeing CEO on safety
US Transportation Sec'y Duffy requests meeting with Boeing CEO on safety
Feb 13, 2025
WASHINGTON (Reuters) - U.S. Transportation Secretary Sean Duffy said on Thursday he has asked the CEO of Boeing to come to Washington, D.C., as soon as possible to discuss quality and safety issues at the company. Following that, I will visit Boeing myself to evaluate firsthand the measures being implemented to ensure its planes meet the highest safety standards, Duffy...
ImmunityBio's Application for Anktiva Approved for Review in UK
ImmunityBio's Application for Anktiva Approved for Review in UK
Feb 13, 2025
03:37 PM EST, 02/13/2025 (MT Newswires) -- ImmunityBio ( IBRX ) said Thursday that the UK's Medicines and Healthcare Products Regulatory Agency accepted its marketing authorization application for Anktiva in combination with bacillus Calmette-Guerin to treat certain patients with non-muscle invasive bladder cancer. The application covers patients who do not respond to bacillus Calmette-Guerin and are with carcinoma in situ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved